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It is remarkable that of the six separate systems of surface antigens identified 
on thymocytes and lymphocytes of the mouse with cytotoxic antisera (1), all 
but  one  (H-2)  are represented  only,  or mainly,  on  these  cell  types. Another 
antigen  system  with  characteristically  limited  tissue  representation  has  re- 
cently been recognized on plasma cells (2). We have referred to such discrimina- 
tory surface components as "differentiation antigens" (1). 
Thus  the  antigenic  constitution  of the  surfaces  of immunocompetent cells, 
and by inference also the spectrum of genes used by these cells to build their 
surface  membranes  (1),  is  characteristic  of  this  pathway  of  differentiation. 
Continuing  our  study  of  the  antigenic  composition  of  cells belonging  to  the 
immune system, we have examined the question "What immunoglobulin com- 
ponents  can  be  identified  as  surface  elements  of  immunocompetent  cells  of 
different types?" There is already a variety of evidence from other laboratories 
that Ig components are in fact detectable on such cells (see review ref. 3). 
To do this we have studied the reactivity of a  range of anti-Ig sera in tests 
with various immunocompetent cell populations,  using the same cytotoxicity 
test system that has been used to identify all the other known surface antigens 
of immunocompetent cells referred to above. The Ig phenotypes of these cells 
were then further defined by testing the ability of various anti-Ig sera to inter- 
fere with their activity in a number of well-defined tests that measure functions 
of immunocompetent cells. 
In  discussion,  we  shall  attempt  to  summarize present  information  on  the 
surface phenotypes of different cells belonging to the various compartments of 
the  immune  system,  including  all  the  known  differentiation  antigens  which 
serve to distinguish  one such population from another,  of which  the Ig com- 
ponents represent one category. 
* This work was supported in part by National Cancer Institute  grant CA 08748 and a 
grant from the John A. Hartford Foundation, Inc. 
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Materials  and Methods 
Mice.--These  were  obtained either from  our colonies or  from  the Jackson Laboratory, 
Bar Harbor, Maine. 
Myelomas  and Other Tnmors.--Three  BALB ascites myelomas, S19 (~3,2a),  $41  (•ot),  and 
S129  (~3~1), were kindly provided by Drs.  R.  Hyman and M.  Cohn of the Salk Institute, 
San Diego, Calif. Other myelomas, leukemias, and sarcomas used in this study were described 
elsewhere (2). 
Antisera.--Antisera  against mouse Ig components were produced as described by Potter 
(4).  Purified myeloma proteins and urinary proteins were used to immunize rabbits, appro- 
priate absorptions being performed as necessary to obtain monospecific sera. 
Cytotoxicity  Tests.--Method  of  Gofer  and  O'Gorman  (5)  with  modifications  (6).  Using 
medium 199 as diluent, tubes were set up containing 0.05 ml each of:  (a)  serial dilutions of 
antiserum,  (b)  guinea pig serum  (GPS) 1 diluted  1/3  or  1/4 as  the  source of  complement 
(C), and (c) cells (5)<  106/ml). These were incubated at 37°C  for 45 rain. The proportion of 
dead  cells was  determined by adding 0.1  ml of a  freshly prepared 0.16%  trypan blue  (to 
stain dead cells) to each tube and counting in a  hemacytometer. 
Each test included controls in which the cells were incubated with either GPS alone,  or 
antiserum (1/4) alone; these never contained more than 10% stained cells and are therefore 
omitted from all tables and figures. 
Detection  of Ig Components  on Hemolytic  Plaque-Forming  Calls  (PFC).--The principle of 
the test is to determine whether treatment of spleen cell suspensions with anti-Ig q-  C  re- 
duces their plaque-forming capacity.  It is expected that PFC carrying the relevant Ig com- 
ponent would be lysed by this procedure (see ref. 2). 
Spleen cell suspensions were prepared from BALB  mice injected intravenously with 0.1 
ml of 20%  (v/v)  sheep erythrocytes  (SE).  Mice were immunized once for IgM  PFC  tests 
and twice for IgG tests. Tubes were set up containing 0.3 ml each of:  (a)  2-6 )<  106 spleen 
cells from these mice,  (b) rabbit antiserum of the selected Ig specificity, or (control) normal 
rabbit serum  (NRS),  diluted  1/12,  and  (c)  1/4 dilution of GPS  (C source);  these were in- 
cubated for 45 rain at 37°C. 
The cells were  then washed  twice and resuspended  in approximately 0.3  ml of diluent; 
0.1 ml was used for each of three plates prepared as described previously  (2).  Medium  199 
was used as diluent. IgM PFC and IgG PFC were developed by  the methods of Jerne et al. 
(7) and Dresser and Wortis (8), respectively. 
Detection  of Ig Components  and  Alloantiget~s on  Rosette-Forming  Cells (RFC).--The prin- 
ciple is similar to that for detecting antigen on PFC  (above). For detecting Ig on RFC,  the 
cells were incubated with anti-Ig but without C  (blocking of Ig sites apparently being suffi- 
cient to inhibit rosette formation, without actual lysis of RFC).  For detecting surface allo- 
antigens, C was included, as in the case of PFC  (above). Cell suspensions were prepared from 
spleens of BALB mice injected intraperltoneally with 0.I ml of 20% (v/v) SE. 
I. Detecting Ig components:  For detecting Ig components on the surface of RFC, 0.4 mI of 
a  suspension containing 2  X  106 spleen cells was incubated for 1 hr with 0.4 ml of a  1/10 
1 Abbreviations  used in this paper:  anti-Ig, a  rabbit antiserum to a mouse immunoglobulin 
component: either type specific  (~,  X)  or class specific (/z, c~, 71,  5'2a, "y2b),  in contrast to 
alloantisera against nonimmunoglobulin components of  the  cell surface;  BALB,  BALB/c; 
B cell,  thymus-independent cell; C, complement; GPS, guinea pig serum; GVH, graft-versus- 
host;  LNC,  lymph  node  cells;  MBLA,  mouse-specific  bone  marrow-derived  lymphocyte 
antigen;  MSLA,  mouse-specific  lymphocyte  antigen;  NMS,  normal  mouse  serum;  NRS, 
normal  rabbit  serum;  PFC,  plaque-forming  cells;  RFC,  rosette-forming  cells;  SE,  sheep 
erythrocytes; T cell, thymus-derived cell. T.  TAKAItASttI,  L.  OLD,  R.  MCINTIRE~  AND  E.  BOYSE  817 
dilution of antiserum of the selected Ig specificity or of NRS;  this and all other procedures 
were carried out in the cold. The cells were then washed twice and resuspended in approxi- 
mately 0.4 ml of medium 199 containing 5°7o fetal calf serum. The technique of suspension- 
centrifugation  (9)  was used to induce rosette formation.  1.6  X  l0  T SE were added  to  2  X 
106 treated spleen cells and centrifuged in a  10 X  75 mm tube at 100 g for 15 rain. The pellet 
was incubated for an additional 30 mifi. The pellet was resuspended to 0.4 ml and approxi- 
mately  15,000  spleen  cells  were  scanned  in  a  hemacytometer  to  determine  the  RFC/105 
cells. 
II.  Detecting alloantlgens:  For  detecting alloantigens on RFC, 0.4 ml each of  (a)  spleen 
cells,  (b)  alloantiserum or  normal mouse serum  (NMS),  diluted  1/10,  and  (c)  1/15  diluted 
rabbit C  absorbed with mouse erythrocytes were incubated for 45 min in a  37°C water bath. 
(Rabbit serum gives better complementation than GPS with most mouse alloantisera.)  The 
cells were then washed twice at 4°C and tested for rosette formation as described above. 
The use of cells exposed to NMS  as the standard for expressing per cent suppression of 
RFC is dictated by the fact that NMS itself has a  variable suppressive effect on RFC. r[his 
is under investigation, particularly in reference to the anti-thymocyte-lymphocyte autoanti- 
bodies that occur naturally in mouse serum (see ref. 10). 
Test for Suppression of the Ig Phenotype of Lymph Node Cells (LNC) and Myeloma Cells 
Exposed to Anti-Ig  Sera.--The procedure  for  modulation of TL  antigens in vitro  (11)  was 
followed.  5  X  106 MOPC-70A  (K'y1)  myeloma cells or BALB LNC were suspended in 1 ml 
of medium 199 containing anti-K, anti-~l,  or NRS  at a  final dilution of  1/15.  Suspensions 
were incubated for 10-60 min at 0°C or 37°C and shaken every 10 mln to keep the cells sus- 
pended.  After  the  selected  period  of  incubation,  the  cells  were  immediately  cooled  in  an 
ice bath, washed twice in the cold, and examined in the cytotoxicity test. 
RESULTS 
I.  Cytotoxicity  Tests with Anti-H Chain  and Anti-L  Chain Sera on  Thymo- 
cytes and LNC (Table 1).--22  class-specific  and type-specific anti-Ig sera were 
tested  against BALB  thymocytes and LNC  (Table I).  30-40%  of LNC  were 
sensitive to anti-# and anti-K. Other strains of mice were tested and all gave the 
same reactions as BALB.  The proportion of LNC killed was not increased by 
combining anti-/~ and anti-~ sera, suggesting that the majority of the susceptible 
cells  carry both/~  and K specificities.  (The anti-/~  and anti-K sera which were 
mixed  together for these particular tests were selected  on the basis that they 
were  monospecific  for /~  and  K,  respectively,  without  the necessity  for  prior 
absorption with immunoglobulin components,  thus avoiding cross-neutraliza- 
tion by free/z  and K determinants.)  Some of the class-specific  or type-specific 
sera among the 22 tested were cytotoxic for thymocytes but this had no relation 
to Ig specificities (see II below). 
II.  The Origin of the Cytotoxic Reaction on Thymocytes (Fig. 1).--As illustrated 
in Fig.  1,  the cytotoxicity of anti-/~  and anti-K sera against LNC  was not ab- 
sorbed by thymocytes but was absorbed by LNC  (or with serum, or with the 
relevant isolated serum components; see V below). In contrast, the cytotoxicity 
of such antisera for thymocytes was  completely absorbed by thymocytes and 
LNC, but not by whole serum. Thus the cytotoxic activity of Ig antisera against 
thymocytes is due to their contamination with anti-cellular antibody, occurring 818  SURFACE  ANTIGENS  OF  CELLS  Or  THE  IMMUNE  SYSTEM 
naturally in  the  rabbit  serum  or induced unintentionally  by immunization. 
(Thymocytes are characteristically much more sensitive than lymphocytes to 
cytolysis by natural heteroantibody.) 
III.  Cytotoxicity  Tests  with  Anti-K  and  Anti-I~  on  cells  of  Various  Tissues 
'FABLE  I 
Cytotoxicity Tests with Anti-H Chain and Anti-L Chain Sera on BALB  LNC* 
Dilution of antiserum 
1/4  I/8  I/4  1/8  1/16  1/32  1/64  1/128 
Thymocytes  Lymph node cells 
% Cells dead 
Anti-H chain sera 
Ant[-/~  <10  <10  31  31  30  31  12  <10 
Anti-a  <  10  <  10  <  10  <  10  <  10  --  --  -- 
Anti-71  <I0  <10  <10  <10  <10  ..... 
Anti-72a  <  10  <  10  <  10  <  I0  <  10  --  --  -- 
Anti-72b  <  10  <  10  <  10  <  10  <  10  --  --  -- 
Anti-L chain sera 
Anti-K  <  10  <  10  40  41  40  37  30  <  l0 
Anti-X  <  10  <  10  12  15  <  10  --  --  -- 
* Sera selected  for lack of cytotoxic activity  for thymocytes,  see  Table  III  for the  reac- 
tions of these sera with myelomas. 
Anti-K 
Anti - X 
CYTOTOXICITY  TEST 
A. Not absorbed  B. Absorbed  with  C.Absorbed with 
,  thymocytes  lymph  node cells 
E 
30  "'",,Thy 
<10~_  ". 
/ 
>95 ~-  ....  -, 
Anti -y. 
_~  5O 
<lO 
\ 
"- NC "17 
,%,,, 
......  -  ....  "~--2  .....  .  ~  "-  .........  _-_'2"2__ 
! 
I 
i2o  ! 
..........  ~  T  ~  , 
Y,~  Y,~  Y64  h  I',6  Y~4  h  Y,~  Y~4 
Dilution of Antiserum 
FIG.  1.  Cytotoxicity  tests  with  anti-K,  anti-X,  and  anti-#  on  lymph  node  cells  (LNC) 
and  thymocytes  (Thy)  (A)  Effect  of preabsorption with  thymocytes  (B)  or LNC  (C). T.  TAKAttASttI,  L.  OLD,  R.  McINTIRE~  AND  E.  BOYSE  819 
(Table H).--Lymphocytes separated from peripheral nodes, mesenteric nodes, 
blood, and peritoneal cavity were all in some proportion sensitive to anti-K and 
anti-#. Spleen contained the highest proportion of cells sensitive to anti-K, and 
bone marrow the lowest. For each cell type the proportion of cells lysed by anti- 
"FABLE IT 
Cytotoxicity Tests with Anti-K and Anti-t~ Sera* on Cells of Various Tissue~ 
Cell type  (BALB) 
Anti-~  Anti-/* 
1/4  1/16  1/64  1/4  1/16  1/64 
% Cells dead 
Thymocytes  <10  <lO  <10  <10  <10  ~ 1O 
Lymphocytes from 
Peripheral nodes  40  37  37  33  31  20 
Mesenteric nodes  35  34  34  32  31  20 
Blood  44  44  43  29  25  19 
Peritoneal cavity  46  36  33  28  29  17 
Spleen cells  55  59  38  36  30  21 
Bone marrow cells  28  26  18  25  24  25 
* Results not affected by preabsorption with thymocytes. 
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FTO. 2. Cytotoxicity tests with anti-T1 and anti-K on MOPC-70A myeloma ceils. 
K was somewhat higher than that lysed by anti-#; therefore particularly in the 
case of spleen, where the discrepancy was considerable, it seems likely that some 
K  + cells carry heavy chains other than/~. 
IV.  Cytotoxicity Tests with Anti-H Chain and Anti-L Chain Sera on Myeloma 
Cells  (Table  III  and  Fig.  2).--Three  transplantable ascites  myelomas were 
tested with the full range of antisera available to us (Table III). One of these, 820  SURFACE  ANTIGENS  OF  CELLS  017  THE  IMMUNE  SYSTEM 
MOPC-70A (K3,1),  was sensitive to anti-K and anti-yl. The other two, MOPC- 
104E  (X/~) and  MPC-67  (Ka),  were  insensitive to  all  other  Ig  antisera.  Five 
more ascites myelomas S129 (K3,1),  S41  (~oz), S19 (K3'2a), Adj-PC5  (Ky2a), and 
MPC-11  (K"/2b)  were  tested  with  anti-K and  appropriate  anti-H chain  sera; 
TABLE  III 
Cytotoxicity Tests with Anti-H Chain and Anti-L Chain Sera* on Myeloma Cells: Summary 
MOPC-70A  MOPC-I04E  MPC-67 
(~vl)  (xu)  (~=) 
Anti-H chain sera 
Anti-/z  -- ** 
Anti-~ 
An  ti-'y  1  + § 
Anti-72a 
Anti-'y2b 
Anti-l, chain sera 
Anti-K  q- 
Anti-~ 
m 
m 
m 
i 
* See Table I for the reactions of these sera with thymocytes and LNC. 
:~ --, no cytotoxic reaction. 
§ +, positive cytotoxic reaction, titer 1/64, see Fig. 2. 
"FABLE  IV 
Specificity  of  Cytotoxic Reactions of Anti-H  Chain and  Anti-L  Chain Sera Confirmed by 
Neutralization with Ig Components 
Antiserum 
Preabsorpfion with 
None  NMS  r-chain  X-chain 
% LNC dead 
Anti-/~  31  < 10  27  35 
Anti-K  37  < 10  < 10  38 
% MOPC-70A cells dead 
Anti-T1  65  < 10  60  62 
Anti-K  90  < 10  < 10  89 
Method: 0.05  ml antiserum (diluted 1/8)  incubated with 0.05  ml (a) NMS  (1/10),  (b) 
d-chains (0.1 mg/ml), or (c) X-chain  (0.1 mg/ml) for 45 min at room temperature  followed 
by 45 min in the cold and then tltrated against LNC or MOPC-70A. 
once again only the n3,1-producing myeloma (S129)  showed  sensitivity to  the 
appropriate anti-Ig sera in the cytotoxicity test  (see Discussion). 
A  titration of anti-K and anti-3,1 against MOPC-70A is shown in Fig. 2.20 
leukemias of different types and from various mouse strains were  tested with 
anti-d, with negative results in all cases. 
V.  Confirmation of the Specificity of the Cytoloxic Reactions of Anti-I~, Anti-3~l, T,  TAKAtIASHI~  L.  OLD~ R.  McINTIRE~  AND  E.  BOYSE  821 
and Anti-K Sera against LNC and Myeloma Cells (Table IV).--The cytotoxicity 
of anti-tz for LNC, and of anti--/1  for MOPC-70A cells, was abolished by pre- 
incubation  of  these  antisera  with  NMS  but  not  with  K-chains  or X-chains. 
Similarly  the  cytotoxic activity of anti-K sera for LNC and  MOPC-70A  cells 
was abolished by incubating the antiserum with NMS or with K-chains, but not 
with ;~-chains. 
TABLE V 
Tests for Ig Components on Hemolytic Plaque-Forming Cells (PFC); Effect of Preincubating 
PFC with Anti-H  and Anti-L Chain Sera 
BAL]~ spleen cells 
(PFC) preincubated with* 
(and complement) 
NRS 
Anti-H chain 
Anti-/z 
Anti-a 
Anti-3,1 
Anti-T2a 
Antl-3'2b 
Anti-L chain 
Anti-K 
Anti& 
Plaques: IgM type 
Exp. 1  Exp. 2 
150 
56  50 
134  92 
152  91 
137  103 
132  97 
74  49 
140  102 
Summ~rylf 
of results: 
degree of 
inhibition 
+++ 
+++ 
Plaques: IgG type 
Exp. 1  Exp. 2 
%  ~  ~  __ 
232  100  I 213  O0 
222  96  202  95 
246  106  213  O0 
235  101  206  97 
210  91  198  93 
214  92  187  88 
213  92  189  89 
197  85  211  99 
Sam- 
maryll 
of re- 
sults: 
degree 
of in- 
hibition 
* Dilution  of all antisera  1/12; conditions  of preincubation  of spleen cells as for cyto- 
toxicity tests. 
:~ Total plaques in three similar plates. 
§ PFC/(PFC with NRS) )  100. 
H  % inhibition:  --  <15, +  16 30, ++  31-50,  +++  51-70,  ++++  71-100. (Based 
on the two results to the left.) 
VI.  Tests for Ig Components on Hemolytic Plaque-Forming Cells  (Table V).-- 
Spleen cells from mice immunized against SE were incubated with anti-H chain 
or anti-L chain sera, together with C. Their plaque-forming capacity was  then 
tested directly for IgM PFC and indirectly (i.e. with added anti-mouse Ig)  for 
IgG PFC. 
IgM PFC cells were suppressed by anti-~ and also by anti-K (50%  or  more 
reduction of plaques in both cases). The controls for these experiments  included 
prior neutralization  of the anti4z and anti-K reagents with NMS, and  substitu- 
tion  of heat-inactivated  C,  both  of which  abolished  the  suppression  of IgM 
PFC. 
In  contrast,  no significant  demonstrable  suppression  of IgG PFC  was  ob- 822  SURFACE  ANTIGENS  OF  CELLS  OF  THE  IMMUNE  SYSTEM 
tained with any of the H  chain or L  chain antisera. We considered the  possi- 
bility that some IgG PFC might indeed be carrying class-specific determinants 
on their surfaces but that for each particular specificity the proportion of cells 
was  too low for  their loss  to  be recognizable as  a  lowering of the number of 
plaques. To cover this possibility a  number of tests were performed in which 
the plaque reaction was  developed with  class-specific antisera instead of  the 
TABLE  VI 
Tests Jbr Inhibition of Rosette-Forming Cells  (RFC)  by 
Anti-H Chain and Anti-L Chain Sera 
Spleen cells (RFC) 
preincubated* with 
NRS 
Anti-H chain 
Anti-g 
Anti-a 
Anti-3,1 
Anti-3,2a 
Anti-T2b 
Anti-I, chain 
Anti-K 
Anti-X 
Day 4:[:  Day 9~: 
Exp. 1  Exp. 2  Exp. 1  i  Exp. 2 
RFC  %11  % 
397  100  100 
I 
159  40  111 
343  86  274 
350  88  267 
287  72  287 
314  79  251 
! 
20  5  26 
429  109  343 
426  ]100 
33  198 
83  306 
82  307 
87  337 
76  297 
8  53 
105  521 
46  366 
71  561 
71  538 
79  389 
69  393 
12  53 
122  663  i 
58 
89 
86 
62 
63 
9 
106 
Summary¶ of 
results: degree 
of inhibition 
+++ 
+ 
+ 
+ 
+ 
++++ 
* 0.4 ml spleen cell suspension (5 X  106/ml) incubated with 1/10 antiserum for 60 min at 
4°C. The cells were then washed and tested for rosette formation. 
BALB mice were immunized with 0.1 ml of 20% (v/v) SE intraperitoneally.  Tests for 
RFC were performed 4 or 9 days later. 
§ Average of two duplicate samples. Approximately 15,000 spleen cells scanned in each 
sample to determine the RFC/105 cells. 
H  RFC/(RFC with NRS)  X  100. 
¶ See footnote II, Table V. 
usual polyspecific anti-Ig. The number of plaques obtained was  considerably 
lower  in  each  case,  as  expected,  but  again preincubation with  class-specific 
antisera in the presence of C produced no detectable suppression of the respec- 
tive IgG PFC. There remains the possibility that unidentified H  chain deter- 
minants are  expressed  on  these  cells, but the  failure of  anti-L chain sera  to 
suppress IgG PFC is against this; no matter what heavy chain determinants 
are expressed on these cells, it is to be expected that they should have either K- 
or X-chains. We conclude that no Ig components are  demonstrable by these 
methods on the surface of IgG PFC. T.  TAKAHASHI~ L.  OLD~ R.  MCINTIRE, AND  E.  BOYSE  823 
The results in this section parallel closely those in section I  above, where it 
was seen that the cytotoxicity test recognizes #  and r  on a proportion of lymph- 
oid cells, but does not recognize cells bearing other Ig components. This does 
not mean they are not there, in fact 3'1 is demonstrable on two myelomas, but 
more likely that the amount on LNC and bone marrow cells is too small to give 
rise to a significantly positive cytotoxicity test. 
VII.  Ig Components and Alloantigens o~ the Surface of Rosette-Forming Cells 
(Tables  V! and VII).--The  major Ig determinants on the surface of RFC are 
#  and r; anti-# inhibited rosette formation by 40-60%  and anti-r by approxi- 
TABLE VII 
Tests for H-2, O, Ly-A, Ly-B, Ly-C, and PC.1 Alloantigens on Rosette-Forming Cells (RFC); 
Effects of Pre-incubating RFC with the Respective Alloantisera 
Spleen cells (RFC) 
preincubated* with 
NMS 
Anti-0-C3H¶ 
Anti-Ly-A.2 
Anti-Ly-B.2 
Anti-Ly-C.2 
Anti-PC.1 
Anti-H-2  ~ 
Day 4:~  Day 7:~ 
Exp. 1  Exp. 2 
RFC§~  %§~  RFC 
675  100  667  ' 
750  111  641 
645  96  587 
545  81  782 
539  80  647 
480  71  516 
27  4  20 
Exp. 1  Exp. 2 
%  RFC  %  RFC  % 
100  539  I 100  844  /  100 
96  859  I 102 
88  737  i  87 
117 
97 
77 
3 
525  97 
654  119 
539  100 
600  111 
378  70 
20  4 
781  92 
683  80 
639  76 
53  6 
Summary of 
results: degre 
of inhibitionN 
u 
m 
+ 
++++ 
* Dilution of serum 1/10, C, 1/8 rabbit serum preabsorbed with mouse thymocytes and 
erythrocytes, conditions of preincubation of spleen cells as for cytotoxicity test. 
:~ A strain mice were immunized with 0.1 ml 20%  (v/v) SE intraperitoneally and tests for 
RFC were performed 4 or 7 days later. 
§ See footnotes §, I[ Table VI. 
H  See footnote II, Table V. 
¶ Prepared by immunization of A/0-AKR congenic mice with A strain (0-C3H) cells. 
mately 90%.  Lesser reductions were observed with  all the  other anti-Ig sera 
with the exception of anti-X (Table VI). These reductions are significant and 
indicate that heavy chains other than/~ are also present on RFC. 
Incubation of spleen cells with H-2  antiserum and  C  virtually abolished all 
RFC. Anti-PC.1 serum (2) reduced RFC by 25-30%. No consistent reduction 
was produced by antisera belonging to the O, Ly-A, Ly-B, or Ly-C systems of 
thymocyte-lymphocyte antigens (1). 
The  usual  0  antisera,  C3H  anti-AKR  and  AKR  anti-C3H  (12),  reduced 
RFC by 30-40%,  as others have reported (13,  14).  This is not due to anti-0, 
however, for 0 antisera prepared in 0-congenic mice, with anti-0 titers as high 
as or higher than the C3H anti-AKR and AKR anti-C3H, gave no reduction of 824  SURFACE  ANTIGENS  OF  CELLS  OF  THE  IMMUNE  SYSTEM 
CYTOTOXICITY  TEST 
A) With lymph  node  cells  B) With  MOPC-70A myeloma 
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FIG.  3.  Suppression of K  +  phenotype of LNC  and  myeloma cells by  exposure to anti-K 
in the absence of complement. LNC  (A)  or MOPC-70A  myeloma cells (/7)  were incubated 
with 1/15 anti-K for a period of 10-60 rain (abscissa) at 0°C or 37°C and then subjected to the 
standard cytotoxicity test with 1/15 anti-K (ordinate  =  per cent cells lysed). (Curves for sensi- 
tivity  to added C  alone, not shown, were similar to  those in  this figure.  Control cells pre- 
incubated in NRS at 37°C, instead of anti-G showed no loss of sensitivity to anti-n.) 
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FIG.  4.  Effect of actinomycin D  on the  K  +  --~ K- surface-phenotype change induced in 
LNC  (A)  and MOPC-70A  myelmna cells  (B). Step  1: LNC  or MOPC-70A  myeloma cells 
incubated in actinomycin D  (5 or 50/zg/ml) for 60 miu at 37°C, then were washed twice in 
the cold. Step 2: Further incubating in 1/15 an  fi-~ or NRS  (control) for 45 min at 37°C;cells 
then washed twice in the cold. Step 3: This figure; cytotoxieity tests with anti-•. 
Interpretation:  actinomycin  D  (50  #g/ml)  inhibited  the  K  +  ~  K-  conversion  of  LNC 
(but not of MOPC-70A myeloma cells) induced by ex?osure to anti<. T.  TAKAHASHI, L.  OLD,  R.  MCINTIRE,  AND  E.  BOYSE  825 
RFC.  This  must  therefore  be an  antibody of another  specificity which reacts 
with RFC. We find that this unknown antibody does not belong to any of the 
Ly specificities  (15)  that  are found in  low titer  in  C3H  anti-AKR  and AKR 
anti-C3H sera. 
VIII. Suppression  of the Surface  Ig Phenotype of LNC  and Myeloma  Cells 
Exposed to Anti-Ig Sara (Fig. 3-5).--As described above, a proportion of LNC 
and MOPC-70A cells are sensitive to lysis by anti-K in the presence of C. How- 
ever, when these cells are incubated with anti-K in the absence of C  their sensi- 
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FIG. 5. Loss of/¢+ "y1  + phenotype  of myeloma cells incubated  in either anti-r or anti-T1 
in the absence of complement. Step 1: MOPC-70A myeloma cells incubated with "1/15 NRS, 
anti-~,  or anti-71  for 60 rain at 37°C, then washed twice in the cold. Step 2: This  figure; 
cytotoxicity tests with anti-~ (A), or anti-71  (B). 
tivity to lysis by C  decreases progressively; finally they become totally insensi- 
tive to added C  and are no longer susceptible  to lysis by the addition of fresh 
anti-K and  C  (Fig.  3).  Thus  the apparent  Ig surface phenotype changes from 
K  + to K-. This change of phenotype did not occur if the cells were incubated  at 
0°C,  and in  the case of LNC,  phenotypic suppression  by anti-K could also be 
inhibited  by actinomycin D,  although  this was not possible with  MOPC-70A 
cells  (Fig.  4).  In  a  similar  manner,  exposure  of MOPC-70A  cells  to  anti-3"l 
serum altered the phenotype from 3"1  + to 3'1- (Fig. 5). 
The presence of both r  and 71  on MOPC-70A cells enabled us to determine 
whether phenotypic suppression  of one of them would entail phenotypic sup- 
pression of the other. It appears that this is the case (Fig. 5). MOPC-70A cells 826  SURFACE  ANTIGENS  OF  CELLS  OF  THE  IMMUNE  SYSTEM 
incubated  with  anti-3,1  became  insensitive  to  both anti-~  and anti-3'l,  and 
MOPC-70A incubated with anti-K also became insensitive to both anti-3'l and 
anti-K. 
DISCUSSION 
Ig and Other Surface Markers on Cells of the Immune Syslem.--Table  VIII 
summarizes what is known of the surface antigens expressed on cells of the im- 
mune system. These data accord with the prevailing view that lymphoid cells 
belong to two major classes,  the thymus-derived (T)  cell and the thymus-in- 
dependent (B) cell originating from bone marrow and thought to be the equiva- 
lent of the bursal cell of avian species (16, 17).  The surface markers of the T 
cell are the 0-Ly-MSLA-TL antigens  (1), and for the B  cell the PC-MBLA 
antigens (2, 18). 
PC evidently is not a good marker for the immature B  cell, for it seems to 
occur rather late in differentiation (see below), at a  time when the B  cell is 
about to become a plasma cell and to secrete Ig. These two sets of markers (T 
versus  B)  appear to be mutually exclusive. We have found no evidence of a 
normal or malignant cell carrying both of them. 
What is the origin of cells bearing demonstrable Ig on their surface? Those 
bearing PC.1 as well as Ig are clearly B cells; in this category are a proportion of 
IgM PFC and of RFC (and ~1  myelomas). Do T  cells also carry Ig markers 
at some time in their history? If so, one might hope to find some cells bearing 
both thymocyte markers and Ig. It has been reported that some rosette-forming 
cells are 0  + (13,  14), but we find that monospecific 0 antisera prepared in con- 
genic mice do not react with RFC; suppression of RFC by the usual anti-0 sera 
(12) is due to an unidentified antibody; this may be recognizing a T cell marker, 
but that has yet to be proved. If indeed some RFC are T  cells, then the T  cell 
must acquire the RFC property late in its history, at a time when 0 and Ly are 
reduced to nondetectable levels. Thus, despite the apparent necessity for surface 
Ig receptors on T cells to account for antigen-recognition, we have not succeeded 
in finding a T  cell surface marker on any Ig  + cell. But it would certainly be 
unjustified to conclude that the Ig  + surface phenotype is confined to B cells. 
Given the facts about the B  and T  cell surface markers, what can be said 
about the origin of the various cell populations examined? The easiest to assess 
are the  clonal populations in Table VIII:  (a)  the lymphatic leukemia  cells, 
which are 0+Ly+PC-Ig- (T cell surface phenotype) and (b) the myeloma cells 
which are ~Ly-PC+Ig  + or- (B  cell surface phenotype). Among normal cells, 
thymocytes (0+Ly+PC-Ig  -)  come  closest  to  being  a  similarly homogeneous 
population. Cell suspensions from other organs contain various proportions of 
0  + and K  + cells (bone marrow 30% K  +, none 0+; spleen 50% K  +, 30% 0+; thoracic 
duct 15% K  +, 80% 0+). Although the minimum proportion of T  cells is given 
by the percentage of cells showing the 0 phenotype, the proportion of B cell is T.  TAKAHASHI~  L.  OLD~ R.  MCINTIRE~  AND  E.  BO¥SE  827 
% 
¢, 
a 
Z 
o 
.t, 
-H 
",,So 
c 
> 
r_b 
t.,,  I 
I..,  I 
+ 
+ 
+ 
+~  I  I 
+~  +$  +,$  i 
x  "~  +  +  ~  + 
~Z'~ 
,,I~  ,  ~  +8+8 
.~  +  ~  +s  +s 
.='~,  +o,  +~,  I  I 
~x 
C 
.._t.  ,.2  ,U.,4 
°~ 
v.~ ~  a 
.,~  ~  ~ 
.£o ~  ,.~  o  "~ 
0',~  ¢~  ,  ~n  .~ 
,.,¢ 
~0=~o  ~.~N 
~  ~  ,-~  "~  ~  ~ 
.~-  ~,~  ~  'F,  =~ 828  SURFACE  ANTIGENS  OF  CELLS  017  THE  IMMUNE  SYSTEM 
uncertain, because we cannot be sure that the K surface phenotype absolutely 
distinguishes B  cells from T  cells. 
What  are  the  relative contributions  of B  and  T  cells  to  the various  cell 
populations concerned in tests of function in vitro and in vivo? (a) Some RFC 
are B  cells  (PC+); the contribution of T  cells to this population is  uncertain 
(as discussed above). (b) Most or all PFC have the B phenotype (PC+).  Pos- 
sibly the B-type RFC which carry surface Ig mature into PFC. One interpreta- 
tion  is  that  the  B  cell mediating  rosette formation is  at  an  early phase  of 
differentiation during which it expresses surface Ig; as it matures to the secretory 
phase, the amount of surface Ig decreases and PC increases. This may signify 
a remodeling of the B cell surface as it undergoes maturation to an Ig-secreting 
end  cell,  perhaps  the  counterpart  of  the  profound transition  in  alloantigen 
representation which the thymocyte experiences in the course of peripheraliza- 
tion (1). (c) The cell population which has the potential to initiate graft-versus- 
host  (GVH)  reactions has  the T  phenotype 0+K  -  (evidently the majority of 
such cells do not have detectible amounts of surface Ig). (d) Antibody forma- 
tion in mice involves in some instances a thymus-dependent function, exempli- 
fied  by  the  response  to  SE  (19,  20),  and  in  others  a  thymus-independent 
function,  exemplified by the  response to Brucella  antigens  (21).  The surface 
phenotypes are  concordant  (22)  since  adoptive immunization  of  the  former 
type was antagonized by 0 antiserum (implicating the T cell) whereas the latter 
was not (Table VIII)  (21). 
The failure of PC  antiserum  to influence adoptive transfer  of primary or 
secondary antibody formation is paradoxical, because antibody-producing cells 
are  PC +  (2).  The  most  likely explanations  are  that:  (a)  PC +  cells  may be 
relatively resistant to radiation, enabling them to survive after the prospective 
recipient has been irradiated in preparation for the test of adoptive immuniza- 
tion (the donor PC + cells would thus be superfluous, and their destruction by 
PC  antiserum immaterial); or (b)  at the time of transfer the cells responsible 
may be  at  an  early stage  of maturation  at  which  we  suspect  the  cell with 
antibody-secretory potential is PC-. (For a discussion of evidence favoring the 
latter interpretation see ref. 22.) 
With  regard to myelomas it  is somewhat surprising  that  the  only surface 
immunoglobulin type found was K3'l rather than K# which is the type demon- 
strable on lymphocytes and IgM PFC. A total of four K3,1-producing  myelomas 
(two in  this report and  two  tested by Princler,  G. L.,  and K.  R.  McIntire, 
unpublished) have been examined; all were sensitive to anti-n and anti-3,1.  Six 
myelomas  of  other  classes  (1>,  2oe, 2y2a,  13,2b) have  not  been  sensitive  to 
anti-Ig sera in cytotoxicity tests. 
Thus we can broadly recognize three Ig surface phenotypes: (a)  surface Ig 
only, no demonstrable secretion, e.g.  the K+#  + lymphoblastic human cell line 
(Daudi,  ref. 2,3) and presumably also  the K+#  + lymphocyte; (b)  secretory Ig T.  TAKAHASHI,  L.  OLD,  R.  McINTIRE,  AND  E.  BOYSE  829 
only, no demonstrable surface Ig,  e.g. most mouse myelomas and IgG PFC; 
and (c) combined surface and secretory type, e.g. K'y1 myelomas and the IgM 
PFC. 
Antibody-Induced  Suppression  of the Ig Phenotype: Anhgenic Modulation?- 
The apparent loss of Ig from the surfaces of cells incubated in anti-Ig sera has 
several features in  common with  antigenic  modulation  described in  the  TL 
system  of antigens  (11).  Both phenomena  are  temperature dependent,  both 
can be suppressed by actinomycin D, and in both instances the loss may include 
specificities not represented in the antiserum responsible for the suppression. 
In the TL system a simple blocking mechanism has been ruled out, and we are 
left with the possibilities that  the modulated antigen has been (a)  exfoliated 
from the  cell,  (b)  ingested  by the  cell,  or  (e)  combined with  antibody in  a 
manner leading to conformational changes at the cell surface which ultimately 
prevent the effective utilization of complement. 
The fact  that  phenotypic suppression  resembling  antigenic  modulation  is 
now seen to affect cell surface Ig determinants adds weight to the suggestion 
(24)  that antigenic modulation of TL antigens may be a  model for "allotype 
suppression" (the suppression of an Ig allotype in the serum of an animal treated 
with antibody to that allotype) (25). The union of anti-Ig with cell surface Ig 
is  an  event that involves the same surface Ig molecule that would normally 
engage  antigen.  Either  stimulus  can  initiate  blastic  transformation  of  the 
lymphocyte (26). In both cases we surmise that this process begins with sup- 
pression of the Ig surface phenotype, as observed in our experiment,  and  in 
the case of the B  cell ends with conversion into the Ig-secretory phenotype. 
SUMMARY 
Immunoglobulim  (Ig)  on cells of the immune system: The cytotoxicity test, 
with class-specific and type-specific anti-Ig sera, identifies K and g  determinants 
on mouse lymphocytes. The proportion of K  +  cells  is  characteristic for  each 
source of cells: 30 % of bone marrow cells, 40 % of cells from peripheral lymph 
nodes,  45 %  of lymphocytes from peripheral blood or peritoneal cavity, and 
50%  of spleen cells.  No Ig was  demonstrable on thymocytes or on leukemia 
cells  (most of which  arise from thymus-derived  [2?] cells).  Cytotoxicity tests 
were performed on various myelomas secreting different Ig; the only positive 
reactions were  given by K~/1 myelomas  (all four K'),I myelomas  tested  were 
sensitive to both anti-K  and anti-'yl). Hemolytic plaque-forming cells (PFC) 
of IgG type had no demonstrable surface Ig,  but a  proportion of IgM  PFC 
were  K+g  +.  Virtually  all  rosette-forming cells  (RFC)  have  surface  Ig,  more 
than 90% of them being inhibited by anti-d, 50% by anti-g, and 10-30% by 
antisera to other heavy chains. Anti-k sera gave no positive reactions with any 
cell type, which is in keeping with the low level of this light chain in mouse 
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Ig and other differentiation  antigens as markers for T and B cells: Thymocytes 
are hallmarked by the alloantigens TL, 0, and the Ly series, and it is generally 
held that extrathymic lymphoid cells that bear them are derived from thymo- 
cytes. There is one alloantigen marker for the  thymus-independent (B)  cell, 
and  that  is  PC,  which  appears  late  in  differentiation.  (The  mouse-specific 
lymphocyte  (MSLA)  and  mouse-specific  bone  marrow-derived  lymphocyte 
(MBLA) antigens recognized by heteroantisera, not used in the present study, 
are other candidates for T  and B cell markers.) Making use of antisera to these 
surface antigens  to inhibit the function of cells that  carry them, we find the 
following: 
Approximately 30% of RFC, 60% of IgM PFC,  and 90% of IgG are PC  + 
and so are identified as B cells. No T  markers were demonstrable on these cell 
populations.  Thus  if T  cells do become RFC  or PFC  they presumably lose 
their T  surface markers  in  the process  (cf. the  quantitative  reduction of  T 
markers accompanying the thymocyte ~  lymphocyte transition). 
Cells  that  have the potential to initiate graft-versus-host  (GVH)  reactions 
have the T  cell surface phenotype 0+Ig  -. 
Adoptive transfer of thymus-dependent antibody-forming capacity (response 
to sheep erythrocytes) required 0  + cells but transfer of a thymus-independent 
immune response to Brucella  antigen did not.  Cells with surface Ig were in- 
volved in both types of adoptive transfers. 
Thus the presently available T  markers do not provide evidence for T  cells 
carrying surface Ig. 
Suppression of the lg phenotype  by antibody:  antigenw modulation?  A pheno- 
typic change from Ig  + to Ig- occurs when Ig  + lymphocytes or myeloma cells 
are incubated with anti-Ig sera in vitro in the absence of complement (C).  As 
with  antigenic modulation  in  the  TL  system,  which  it  resembles,  this  phe- 
nomenon is temperature dependent and in the case of lymph node cells (LNC) 
can be inhibited by high doses of actinomycin D. 
Note Added in Proof.--Subsequent  tests show RFC to be MSLA- and a high pop- 
ulation of them MSPCA  +. The antigen MSPCA (mouse-specific plasma cell antigen) 
identified  by certain absorbed  rabbit anti-mouse  myeloma sera is a  differentiation 
antigen of Ig-secreting  cells, and is absent from T cells (manuscript in preparation). 
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